Source: Owler

Recro Pharma, Inc.: Recro Pharma's revenue changed from $75.36M in Dec 2021 to $80.15M in Sep 2022

Recro Pharma’s Trailing Twelve Months revenue changed from $75.36M in Dec 2021 to $80.15M in Sep 2022 increasing 6.4% in this time period.

Read full article »
Annual Revenue
$25-100M
Employees
250-500
Gerri Henwood's photo - President & CEO of Recro Pharma

President & CEO

Gerri Henwood

CEO Approval Rating

94/100

Read more